Emerging Growth Drivers in the Infectious Disease Therapeutics Market Landscape: Infectious Diseases On The Upswing A Global Health Concern
Discover trends, market shifts, and competitive outlooks for the infectious disease therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Projected CAGR for the Infectious Disease Therapeutics Market Size from 2025 to 2034?
The market for therapeutics for infectious diseases has seen significant expansion in recent times. Projected growth forecasts a rise from $141.08 billion in 2024 to $151.04 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.1%. This growth through the historical period can be traced back to the increasing occurrence of infectious diseases, an uptick in viral disease cases, enhanced understanding of diagnosis, increasing need for quick and efficient diagnostic testing, rising demand for affordable generic medication, an upsurge in prevalence of infectious diseases and the growing significance of antimicrobial stewardship.
The market size for therapeutics of infectious diseases is predicted to witness a robust expansion in the coming years, ballooning to a valuation of $196.5 billion in 2029, signaling a compound annual growth rate (CAGR) of 6.8%. This anticipated growth over the predicted period can be credited to factors such as rising financial investments, the broadening of clinical trial studies, a growing number of clinical trials, heightened emphasis on the prevention of infectious diseases, increased conscientiousness about early diagnosis, and increased awareness as well as funding. The prediction period is also expected to see major trends like partnerships, product approvals, investments, and research and advancements in the field of therapeutics.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15594&type=smp
Which Factors and External Forces Are Driving Demand in the Infectious Disease Therapeutics Market?
The escalating occurrence of infectious ailments is projected to drive the expansion of the infectious disease therapeutics market in the foreseeable future. These diseases arise due to pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or prions. The surge in infectious illnesses can be attributed to several pivotal aspects like climatic alterations and environmental disruption, antimicrobial resistance, compromised immune systems, increased interactions with animals, and ecological disturbances. Infectious disease therapeutics are crucial in treating infections, diminishing morbidity and mortality rates, and managing the dissemination of communicable diseases within communities and across entire populations. For example, the Centers for Disease Control and Prevention, a US-based government agency, stated in November 2023 that in 2022, the United States reported 8,331 cases of tuberculosis (TB), leading to an incidence rate of 2.5 per 100,000 individuals. This indicates a 5.9% increase in the number of cases and a 5.5% rise in the incidence rate in comparison to 2021. Consequently, the mounting prevalence of infectious diseases fuels the growth of the infectious disease therapeutics market.
Which Primary Segments of the Infectious Disease Therapeutics Market Are Driving Growth and Industry Transformations?
The infectious disease therapeutics market covered in this report is segmented –
1) By Type: Drugs, Vaccines
2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases
3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users
Subsegments:
1) By Drugs – Antibiotics, Antivirals, Antifungals, Antiparasitics, Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)
2) By Vaccines – Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Mrna Vaccines, Dna Vaccines, Toxoid Vaccines
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15594&type=smp
What Are the Fastest-Growing Geographies in the Infectious Disease Therapeutics Market?
North America was the largest region in the infectious disease therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Infectious Disease Therapeutics Market?
Key players in the infectious disease therapeutics market are channeling their resources towards the development of superior treatments for infectious diseases. This includes efforts to tackle antimicrobial resistance, enhance their range of offerings, and respond to imminent infectious threats. By doing so, these companies aim not only to improve the health outcomes for patients, but also to fulfill unmet medical requirements and assist in the worldwide public health initiatives to manage and control infectious diseases. For example, in June 2022, GSK, a healthcare company based in the UK, allocated £1 billion ($1.09 billion) to address infectious diseases in less wealthy nations proactively. The goal of this initiative is to boost research and development activities to fight diseases that have a greater impact on these parts of the world. There is a glaring inequity in the distribution of health research funding and resources between affluent and low- or middle-income nations, highlighting the pressing need for such forward-thinking investments to promote equitable health improvements across populations.
View the full report here:
What Parameters Are Used to Define the Infectious Disease Therapeutics Market?
Infectious disease therapeutics refers to the various treatments and interventions aimed at combating illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites. The goal of infectious disease therapeutics is to either eliminate the infectious agent from the body or to control its replication and spread, thereby alleviating symptoms, preventing complications, and ultimately promoting recovery.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15594
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
